The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Neuroprotective Therapy for PD Using Stabilizers of the LRRK2:14-3-3 Interaction, Supplement
Study Rationale: Our previous work shows that regulation of the phosphorylation of the Parkinson’s disease protein ‘leucine-rich repeat kinase 2’ (LRRK2) is a key mechanism controlling LRRK2...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025Assessing Pre-clinical Efficacy of Brain-penetrant TRPML1 Agonists to Treat Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is characterized by the accumulation of misfolded and aggregated alpha-synuclein inside neurons in the brain. This may either arise from, or be exacerbated by...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025ACT-02 as a Disease-modifying Therapy for Parkinson’s
Study Rationale: Parkinson’s disease (PD) is a complex neurodegenerative disorder marked by the loss of dopaminergic neurons, however the underlying exact reasons are still not fully understood...
-
Research Grant, 2025Phenotypic and Construct Validity of Pink1-/- in Pre-clinical Models for Pre-clinical Parkinson’s Research
Study Rationale: Parkinson’s disease is a common neurodegenerative disorder that is usually diagnosed in people between 60 and 65 years old, but it likely starts about 20 years earlier. During this...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Evaluating Modifiable Risk Factors for Parkinson’s Disease in the Global Burden of Disease Study
Study Rationale: Parkinson’s disease is becoming more and more common over time, but we don’t know why. We will assess how much five key risk factors increase the risk of developing Parkinson’s...
-
Research Grant, 2025Characterization of Research Antibodies for Parkinson’s Community-nominated Targets
Study Rationale: Antibodies are essential for detecting proteins, but nearly 50% of commercial antibodies fail to work reliably—like a GPS that’s only right half the time. In Parkinson’s research...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.